Related Experiment Videos
Critical care pharmacotherapy: issues and approaches
1Director of Pharmacotherapy Services, IC-USA, Inc., Baltimore, MD, USA.
Current Opinion in Critical Care
|May 1, 2001
Summary
Critical care pharmacists improve patient care and reduce drug costs in intensive care units. Further research should explore their impact on patient outcomes and healthcare economics.
Area of Science:
- Pharmacology
- Intensive Care Medicine
- Health Economics
Background:
- Critically ill patients exhibit unique pharmacokinetic and pharmacodynamic profiles.
- Optimal care requires an intensivist-led multidisciplinary team.
- Specialized critical care pharmacists are integral to this team.
Purpose of the Study:
- To highlight the role of critical care pharmacists in optimizing patient care.
- To review the impact of critical care pharmacists on drug costs and care quality.
- To advocate for further research into the broader outcomes of critical care pharmacy services.
Main Methods:
- Literature review and synthesis of existing evidence on critical care pharmacy interventions.
- Analysis of documented cost reductions and quality improvements.
- Identification of areas for future research, including pharmacoeconomic outcomes.
Main Results:
- The presence of a critical care pharmacist is linked to decreased drug expenditures.
- Critical care pharmacists enhance the overall quality of patient care.
- Evidence suggests improved patient outcomes and healthcare system efficiencies.
Conclusions:
- Critical care pharmacists are essential members of the multidisciplinary team for critically ill patients.
- Their involvement leads to significant cost savings and improved care quality.
- Future studies must evaluate the impact on morbidity, mortality, and healthcare system costs to prevent cost-shifting.